نتایج جستجو برای: opv

تعداد نتایج: 853  

Journal: :The Journal of infectious diseases 2014
Kimberly M Thompson Radboud J Duintjer Tebbens

BACKGROUND Oral poliovirus vaccine (OPV) results in an ongoing burden of poliomyelitis due to vaccine-associated paralytic poliomyelitis and circulating vaccine-derived polioviruses (cVDPVs). This motivates globally coordinated OPV cessation after wild poliovirus eradication. METHODS We modeled poliovirus transmission and OPV evolution to characterize the interaction between population immuni...

Journal: :Journal of clinical microbiology 2011
Stephanie B Troy Leticia Ferreyra-Reyes Chunhong Huang Nadim Mahmud Yu-Jin Lee Sergio Canizales-Quintero Harry Flaster Renata Báez-Saldaña Lourdes García-García Yvonne Maldonado

During replication, oral polio vaccine (OPV) can revert to neurovirulence and cause paralytic poliomyelitis. In individual vaccinees, it can acquire specific revertant point mutations, leading to vaccine-associated paralytic poliomyelitis (VAPP). With longer replication, OPV can mutate into vaccine-derived poliovirus (VDPV), which causes poliomyelitis outbreaks similar to those caused by wild p...

Journal: :Japanese journal of infectious diseases 2009
Tamie Sugawara Yasushi Ohsuka Keiko Taya Yoshinori Yasui Noriyuki Wada Masasi Sakano Rie Koshida Fumitoshi Fujii Senko Shibata Goutaro Hashimoto Hiromi Utsumi Masami Sumitomo Michiyo Ishihara Hirokazu Kondo Hiroshi Sato Kumi Ueno Kazuko Araki Nobuhiko Okabe

Using the adverse events monitoring system of Japan, we observed diarrhea cases in approximately 10% of patients who received oral poliovirus vaccine (OPV). This study was conducted to investigate whether diarrhea among children aged 0 to 1 is caused by OPV or by other factors such contact at the doctor's office and/or with others outside the home. We conducted a survey of the health of childre...

2015
Radboud J. Duintjer Tebbens Kimberly M. Thompson

BACKGROUND The Global Polio Eradication Initiative plans for coordinated cessation of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (i.e., OPV2 cessation) followed by the remaining two OPV serotypes (i.e., OPV13 cessation). The risk of circulating vaccine-derived poliovirus (cVDPV) outbreaks after OPV cessation of any serotype depends on the serotype-specific popul...

Journal: :Revista Paulista de Pediatria 2009

Journal: :PLoS ONE 2008
Christine Stabell Benn Ane Bærent Fisker Amabelia Rodrigues Henrik Ravn Erliyani Sartono Hilton Whittle Maria Yazdanbakhsh Peter Aaby

BACKGROUND The policy to provide oral polio vaccine (OPV) at birth was introduced in low-income countries to increase coverage. The effect of OPV at birth on overall child mortality was never studied. During a trial of vitamin A supplementation (VAS) at birth in Guinea-Bissau, OPV was not available during several periods. We took advantage of this "natural experiment" to test the effect on mort...

2015
Kimberly M. Thompson Radboud J. Duintjer Tebbens

BACKGROUND World leaders remain committed to globally-coordinated oral poliovirus vaccine (OPV) cessation following successful eradication of wild polioviruses, but the best timing and strategy for implementation depend on existing and emerging conditions. METHODS Using an existing integrated global poliovirus risk management model, we explore alternatives to the current timing plan of coordi...

Journal: :Vaccine 2014
Hitoshi Murakami Makoto Kobayashi Masahiko Hachiya Zahir S Khan Syed Q Hassan Shinsaku Sakurada

BACKGROUND Refusal of the oral polio vaccine (OPV) is a difficulty faced by the Polio Eradication Initiative (PEI) in multiple endemic areas, including the Khyber Pakhtunkhwa Province (KPP), Pakistan. In 2007, we investigated community perceptions of the OPV and estimated the prevalence of OPV refusal in three districts in Swat Valley, KPP, a polio-endemic area. METHODS Qualitative data conce...

Journal: :The Journal of infectious diseases 2001
E Roilides T Sein M Roden R L Schaufele T J Walsh

tent aliquots are used, 1 nonresponder would be expected only among 10 million OPV recipients. To conclude, stabilized OPV will boost global plans to eradicate poliomyelitis by 2005 [8]. Multiple doses of potent OPV will be an asset to disease surveillance and will stop wild-virus transmission in Angola and elsewhere. Stabilized formulations will enhance the probability of every OPV recipient r...

N. Bordbar S. Soleimani,

Stability studies play a critical role in assuring product quality at all points in the vaccine life cycle. These studies used to determine vaccine expiry date and vaccine efficacy. Accelerated stability and long term stability study performed for three batches of trivalent oral poliomyelitis vaccine (OPV) and three batches of monovalent OPV (type1) manufactured by Razi institute. After samplin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید